Prestigious Prize Recognizes Pioneering Immune System Research

This year's Nobel Prize in medical science has been awarded for transformative discoveries that illuminate how the body's defense network targets harmful pathogens while protecting the body's own cells.

Three renowned researchers—from Japan Shimon Sakaguchi and US scientists Mary Brunkow and Dr. Ramsdell—received this accolade.

The research identified specialized "sentinels" within the defense system that remove malfunctioning defense cells capable of harming the body.

These findings are now paving the way for innovative treatments for autoimmune diseases and malignancies.

These laureates will share a monetary award worth 11 million Swedish kronor.

Decisive Findings

"Their research has been essential for understanding how the body's defenses functions and the reason we do not all suffer from severe self-attack conditions," stated the chair of the award panel.

This trio's research explain a fundamental question: How does the immune system defend us from numerous infections while leaving our own tissues unharmed?

The immune system employs immune cells that search for indicators of infection, even pathogens and germs it has not met before.

Such cells employ sensors—known as recognition units—that are generated randomly in a vast number of combinations.

That gives the immune system the ability to combat a broad range of invaders, but the randomness of the process unavoidably creates immune cells that can attack the body.

Security Guards of the Body

Researchers earlier understood that some of these problematic defense cells were eliminated in the immune organ—the site where immune cells mature.

This year's award honors the discovery of T-reg cells—described as the immune system's "security guards"—which travel through the body to neutralize other immune cells that attack the body's own tissues.

We know that this mechanism malfunctions in autoimmune diseases such as juvenile diabetes, multiple sclerosis, and RA.

A Nobel panel stated, "These discoveries have laid the foundation for a new field of investigation and spurred the development of new therapies, for instance for cancer and autoimmune diseases."

In cancer, T-regs block the body from attacking the tumor, so studies are focused on reducing their quantity.

In autoimmune diseases, trials are exploring increasing T-reg cells so the body is no longer being harmed. A comparable approach could also be effective in reducing the risks of transplanted organ failure.

Innovative Experiments

Prof Shimon Sakaguchi, from a Japanese institution, conducted experiments on rodents that had their immune gland extracted, causing autoimmune disease.

The researcher showed that injecting immune cells from other mice could prevent the disease—suggesting there was a system for blocking immune cells from harming the host.

Dr. Brunkow, from the Institute for Systems Biology in a US city, and Fred Ramsdell, now at a biotech firm in San Francisco, were studying an inherited immune disorder in rodents and people that led to the discovery of a genetic factor critical for the way T-regs operate.

"The pioneering work has uncovered how the body's defenses is kept in check by regulatory T cells, stopping it from accidentally targeting the healthy cells," said a prominent biological science expert.

"This research is a striking illustration of how fundamental biological study can have broad consequences for public health."